SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Female Health FHCO
VERU 2.560+0.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Glenn Petersen who wrote (80)4/30/2015 8:37:29 AM
From: Glenn Petersen  Read Replies (1) of 211
 
The Female Health Company Reports Second Quarter and First Half FY2015 Operating Results

Record Quarter Unit Sales, Net Revenues and Gross Profit

Second Quarter and Year-To-Date Highlights:
- Net revenues increased 153% to $11.0 million and Gross Profit rose 168% to $6.4 million in second quarter.
- Net revenues increased 60% to $17.6 million and Gross Profit rose 68% to $10.2 million in first half FY2015.
- Unit sales totaled 20.8 million in second quarter and 32.9 million in first half of FY2015.
- Operating income of $4.4 million and operating margin of 25% in first half of FY2015.
- Diluted EPS of $0.09 in first half of FY2015 as compared to $0.06 in first half FY2014.
- Brazil orders 25 million units, approximately 19 million units shipped in first two quarters of FY2015.
- Adjusted EBITDA of $3.3 million and adjusted diluted EPS of $0.11 in second quarter.
- Adjusted EBITDA of $5.1 million and adjusted diluted EPS of $0.18 in first half of FY2015.

<snip>

finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News